Clinical Response Predictive Model for Omalizumab in Moderate-to-Severe Asthma Patients

<div>The change of total level of serum IgE and blood eosinophils counts from baseline to 4 weeks, 8 weeks, 12 weeks, and 16 weeks: (a) total level of serum IgE; (b) blood eosinophils counts.</div>

International Journal of Clinical Practice

fig3

Figure 3

Figure 3: Clinical Response Predictive Model for Omalizumab in Moderate-to-Severe Asthma Patients 